Erik Eliasson

Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population

Ümit Yaşar, Erik Eliasson, Marja-Liisa Dahl et al. · Biochemical and Biophysical Research Communications · 1999 · 252 citations

Genetic Analysis, Allelic Variant, Genetic Testing +13

Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the <i>CYP2C9</i> genotype

Ümit Yaşar, Cecilia Forslund‐Bergengren, Gunnel Tybring et al. · Clinical Pharmacology & Therapeutics · 2002 · 182 citations

Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures

Erik Eliasson, Inger Johansson, Magnus Ingelman‐Sundberg · Biochemical and Biophysical Research Communications · 1988 · 170 citations

Hepatology, Biochemistry, Alcohol Dehydrogenases +15

Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.

Erik Eliasson, J G Kenna · Molecular Pharmacology · 1996 · 170 citations

Role of CYP2C9 polymorphism in losartan oxidation.

Ümit Yaşar, Gunnel Tybring, Mats Hidestrand et al. · PubMed · 2001 · 151 citations

Molecular Biology, Molecular Genetics, Pharmacotherapy +17